AED — Stock Film
STOCK FILMSCENE 1/9AED · $25.52
Stock Expert AI presents
AED
Aegon N.V. PERP CAP SECS
~3 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Aegon N.V. PERP CAP SECS. A quick introduction.

On the stock market since 2005, it operates in the world of money and finance. It has 15,700 employees. Now — the numbers.

on the stock market since 2005
16K employees
$52B market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $4 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 4%

This is an established company with proven profits.

THE SALES TREND
Sales have been shrinking.

An average decline of 13% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$46B
2021
$54B
2022
$30B
2023
$20B
2024
$27B
2025
THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Growth has stalled2/10
Costs eat into the margin4/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
Bumpy, but the direction is up.

The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.

THE BRIGHT SIDE

Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.

1
THE RISKS · 1/2
Sales are shrinking

Over the last 3 years, sales fell about 21% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.

2
THE RISKS · 2/2
A rich price tag

The company’s market value is 53 times its annual profit. Even a small disappointment could hit the price hard.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, AED sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: AED is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film